There is evidence from both human cancers and model systems that the activation of STAT5 is associated with less aggressiveness and increased sensitivity to chemotherapy of breast cancers that also display activation of STAT3 [33], and that this may be mediated by repression by STAT5 of genes that are otherwise upregulated by STAT3 [34]. Here, STAT3 is linked to cancer.